Theravance Biopharma, Inc. (TBPH)
17.55
+0.02
(+0.11%)
USD |
NASDAQ |
Dec 17, 10:03
Theravance Biopharma Accounts Payable (Quarterly): 2.213M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 34.45M |
| Assertio Holdings, Inc. | 14.66M |
| Skye Bioscience, Inc. | 2.825M |
| FibroGen, Inc. | 5.093M |
| VYNE Therapeutics, Inc. | 1.197M |